Literature DB >> 19126408

LOX-1 dependent overexpression of immunoglobulins in cardiomyocytes in response to angiotensin II.

Bum-Yong Kang1, Changping Hu, Sastry Prayaga, Magomed Khaidakov, Tatsuya Sawamura, Ki-Bae Seung, Jawahar L Mehta.   

Abstract

LOX-1, a cell surface lectin-like receptor, is upregulated by oxidized low-density lipoprotein (ox-LDL) and angiotensin II (Ang II), and plays an important role in host defense. The specific C-type lectin domain on LOX-1 is essential for ox-LDL binding and internalization, generation of oxidant species and eliciting immune response. Here, we show that LOX-1 deletion alters genes that relate to immune response. Microarray (and qPCR) analysis of cardiac tissues showed downregulated expression of several immunoglobulins (Igk-V8, Igk-C, Igh-6, Igj, Ighg, Igh, and Igl-V1) in the LOX-1 knockout (KO) mice [p<0.05 vs. the wild-type (WT) mice]. The expression of these immunoglobulins was upregulated several-fold in the LOX-1 KO mice hearts when these mice were infused with Ang II (p<0.05, vs. WT mice). Importantly, cultured mouse HL-1 cardiomyocytes expressed these immunoglobulins, and pretreatment of cardiomyocytes with a specific anti-LOX-1 antibody enhanced the generation of immunoglobulins upon subsequent exposure to Ang II. These observations mirrored the data obtained from WT and LOX-1 KO mice hearts in the resting state and following Ang II infusion. This study provides first set of data on immunoglobulin expression in cardiac tissues of WT and LOX-1 KO mice and in cultured HL-1 cardiomyocytes, and demonstrates that LOX-1 inactivation leads to upregulation of immunoglobulins in cardiomyocytes upon challenge with Ang II.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19126408     DOI: 10.1016/j.bbrc.2008.12.143

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

Review 1.  Innate immunity and cardiomyocytes in ischemic heart disease.

Authors:  Li Lin; Anne A Knowlton
Journal:  Life Sci       Date:  2014-01-28       Impact factor: 5.037

2.  IgG and IgA with potential microbial-binding activity are expressed by normal human skin epidermal cells.

Authors:  Dongyang Jiang; Jing Ge; Qinyuan Liao; Junfan Ma; Yang Liu; Jing Huang; Chong Wang; Weiyan Xu; Jie Zheng; Wenwei Shao; Gregory Lee; Xiaoyan Qiu
Journal:  Int J Mol Sci       Date:  2015-01-23       Impact factor: 5.923

3.  Aberrant high expression of immunoglobulin G in epithelial stem/progenitor-like cells contributes to tumor initiation and metastasis.

Authors:  Qinyuan Liao; Wei Liu; Yang Liu; Fulin Wang; Chong Wang; Jingxuan Zhang; Ming Chu; Dongyang Jiang; Lin Xiao; Wenwei Shao; Zhengzuo Sheng; Xia Tao; Lei Huo; C Cameron Yin; Youhui Zhang; Gregory Lee; Jing Huang; Zihai Li; Xiaoyan Qiu
Journal:  Oncotarget       Date:  2015-11-24

4.  IGK with conserved IGΚV/IGΚJ repertoire is expressed in acute myeloid leukemia and promotes leukemic cell migration.

Authors:  Chong Wang; Miaoran Xia; Xiaoping Sun; Zhiqiao He; Fanlei Hu; Lei Chen; Carlos E Bueso-Ramos; Xiaoyan Qiu; C Cameron Yin
Journal:  Oncotarget       Date:  2015-11-17

5.  Next-Generation Sequencing Revealed a Distinct Immunoglobulin Repertoire with Specific Mutation Hotspots in Acute Myeloid Leukemia.

Authors:  Miaoran Xia; Lina Wu; Xiaoping Sun; Xin Han; Huige Yan; Jing Huang; Youhui Zhang; Zhihong Hu; Youli Zu; C Cameron Yin; Xiaoyan Qiu
Journal:  Biology (Basel)       Date:  2022-01-19

6.  Astragaloside IV promotes pharmacological effect of Descurainia sophia seeds on isoproterenol-induced cardiomyopathy in rats by synergistically modulating the myosin motor.

Authors:  Xingkai Liu; Qian Chen; Xuming Ji; Wanchen Yu; Tong Wang; Juanjuan Han; Shumu Li; Jianan Liu; Fangang Zeng; Yao Zhao; Yanyan Zhang; Qun Luo; Shijun Wang; Fuyi Wang
Journal:  Front Pharmacol       Date:  2022-08-11       Impact factor: 5.988

7.  Expression of immunoglobulin A in human mesangial cells and its effects on cell apoptosis and adhesion.

Authors:  Hui Deng; Junfan Ma; Ziyang Jing; Zhenling Deng; Yaoxian Liang; Lata A; Yang Liu; Xiaoyan Qiu; Yue Wang
Journal:  Mol Med Rep       Date:  2018-02-02       Impact factor: 2.952

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.